Headlines & Global News

<img alt="" height="1" width="1" />
FDA review of Glaxo/Theravance lung drug seen as positive
By Toni Clarke. WASHINGTON | Mon Apr 15, 2013 3:48pm EDT. WASHINGTON (Reuters) - An experimental treatment for smoking-related lung damage received a better-than-expected initial review from the U.S. Food and Drug Administration, potentially ...
Theravance Rises on Report on Lung Drug: San Francisco MoverBusinessweek
Experimental Glaxo/Theravance Lung Drug Gets Positive Initial FDA ReviewHeadlines & Global News
The FDA Helps Investors Breathe WellMotley Fool
FierceBiotech -NASDAQ -MSN Money
all 14 news articles &raquo;